Purchase Order HHSD2002017M95721P

Award Date 9/12/17
Potential Completion Date 3/11/18
Potential Value $150K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal SBIR Phase II contract award to Carrera Bioscience Inc., a for-profit, economically disadvantaged woman-owned small business, by the Centers for Disease Control and Prevention (CDC). The contract, valued at $604,500.00, is a Cost Plus Fixed Fee definitive contract with a completion date of September 25, 2018. The contract does not have a set-aside designation. Based on the SBIR Phase II designation, this award is likely part of the CDC's small business innovation research...
<p>This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Ifyber LLC, a for-profit limited liability company. The contract has a firm fixed price of $149,982.96 and was awarded on August 27, 2018, with a completion date of August 12, 2019. The place of performance is Ithaca, NY. This SBIR Phase I award does not have a set-aside designation.</p>
<p>The U.S. Centers for Disease Control and Prevention (CDC) awarded a $242,905.00 Small Business Innovation Research (SBIR) Phase I contract to Mifi, LLC, a woman-owned small business, for SBIR Topic 36. The firm fixed price purchase order was awarded on September 16, 2024 and has an ultimate completion date of March 30, 2025. The contract is set aside for total small business and supports the CDC's research and development initiatives in Stillwater, Oklahoma.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbplex Inc., a minority-owned, economically disadvantaged women-owned small business. The contract has a ceiling value of $987,059.00 and is a Cost Plus Fixed Fee definitive contract. The period of performance runs from September 28, 2015 to September 27, 2017. The contract does not have a set-aside designation. Based on the SBIR program description, this...
This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to JSR Associates Inc., a woman-owned small business. The contract, with a potential value of $149,919.00, is for a web-based application to enable healthy behaviors. The contract was awarded under the total small business set-aside within the SBIR program, which aims to stimulate innovation and increase the commercialization of federally-supported research results.
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) Pittsburgh office to Micron Biomedical Inc., a for-profit small business. The $150,000 contract is for SBIR Phase 1 research and development of &quot;other functions&quot; under Topic 31, with a period of performance ending on March 10, 2017. The work is being performed in Atlanta, Georgia. Micron Biomedical Inc. is a manufacturer of...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to the National Institute For Scientific And Industrial Research, a non-profit organization, on September 18, 2017. The contract, which does not have a set-aside designation, is for critical functions with a potential value of $147,000.00. The period of performance for this contract is through January 17, 2019, and the place of performance is in Atlanta,...
This is a federal contract award to Cyberdata Technologies, Inc., a minority-owned, woman-owned small business, for Information Technology (IT) and Public Health Services. The contract was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $36,111,225.72, is a Delivery Order under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide...
This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...
This is a federal contract award to Ihrc, Incorporated, a small disadvantaged, woman-owned business, by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $146,621.16, is for the delivery of various technical services including occupational health, safety engineering, laboratory science, industrial hygiene, and data analysis to support the CDC's public health mission. The contract is a...

This is a SBIR Phase I contract award to Cytoimage Inc., a woman-owned small business, by the Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (HHS). The award is for $149,531.00 and is a firm fixed price contract. The contract does not have a set-aside designation. The period of performance is from September 12, 2017 to March 11, 2018, with work to be performed in Atlanta, Georgia. The SBIR (Small Business Innovation Research) program is a competitive awards-based program that enables small businesses to engage in federal research and development with the potential for commercialization.

Generated 3/23/24, 2:00 AM